Alzheimer's Drug Discovery Foundation is the famous Corporate Investor, which was founded in 1998. The main department of described Corporate Investor is located in the New York. The fund was located in North America if to be more exact in United States.
The fund was created by Leonard Lauder, Ronald S. Lauder.
This Alzheimer's Drug Discovery Foundation works on 11 percentage points less the average amount of lead investments comparing to the other organizations. Considering the real fund results, this Corporate Investor is 71 percentage points more often commits exit comparing to other organizations. The higher amount of exits for fund were in 2015. The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2019. Deals in the range of 1 - 5 millions dollars are the general things for fund.
Among the most successful fund investment fields, there are Genetics, Health Diagnostics. Among the most popular portfolio startups of the fund, we may highlight Metabolic Solutions Development, Oryzon Genomics, AgeneBio. The fund has specific favorite in a number of founders of portfolio startups. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.
The typical case for the fund is to invest in rounds with 1-2 participants. Despite the Alzheimer's Drug Discovery Foundation, startups are often financed by National Institutes of Health, Hopen Life Science Ventures, Dolby Family Ventures. The meaningful sponsors for the fund in investment in the same round are Dolby Family Ventures, W Fund, National Institutes of Health. In the next rounds fund is usually obtained by W Fund, Michael Montgomery, Kayne Anderson Capital Advisors.
Related Funds
Fund Name | Location |
Arborview Capital | Chevy Chase, Maryland, United States |
Blue Crosss Blue Shield Of Florida | Florida, Jacksonville, United States |
CSC Upshot | California, Palo Alto, United States |
Inter-Asia Venture Management | China, Hong Kong, Hong Kong Island |
Jacaranda Partners | California, Pasadena, United States |
Juhua Group | China, Hangzhou, Zhejiang |
LSC Communications | Chicago, Illinois, United States |
MadDog Ventures | Birmingham, Michigan, United States |
Meruelo Capital Partners | California, Downey, United States |
Ocean Energy | - |
River Head Capital | Chaoyang, China, Liaoning |
SINBON Electronics | Taipei, Taiwan |
Solon | Arizona, Tucson, United States |
Stripe | California, San Francisco, United States |
Synthetic Genomics | California, La Jolla, United States |
Tailwind Capital | New York, New York, United States |
The Growth Fund | Australia, New South Wales, Sydney |
YSS Capital | Central, Central Region, Singapore |
YUL Ventures | Canada, Montréal, Quebec |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Neuro Therapia | $12M | 06 Aug 2024 | Ohio, Illinois, United States | ||
RetiSpec | $10M | 26 Jul 2024 | Old Toronto, Ontario, Canada | ||
BrainScope Company | 19 Sep 2023 | Bethesda, Maryland, United States | |||
Astrocyte Pharmaceuticals | $6M | 18 Aug 2023 | Cambridge, Massachusetts, United States | ||
Therini Bio | $36M | 27 Apr 2023 | San Francisco, California, United States | ||
Cognito Therapeutics | $73M | 22 Mar 2023 | Cambridge, Massachusetts, United States | ||
Imaginostics | $725K | 06 Sep 2022 | Cambridge, Massachusetts, United States | ||
MindImmune Therapeutics | $12M | 30 Jun 2022 | Rhode Island, United States | ||
Optina Diagnostics | $2M | 24 Jan 2022 | Montreal, Quebec, Canada |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Neuro Therapia | $12M | 06 Aug 2024 | Ohio, Illinois, United States | ||
RetiSpec | $10M | 26 Jul 2024 | Old Toronto, Ontario, Canada | ||
BrainScope Company | 19 Sep 2023 | Bethesda, Maryland, United States | |||
Astrocyte Pharmaceuticals | $6M | 18 Aug 2023 | Cambridge, Massachusetts, United States | ||
Therini Bio | $36M | 27 Apr 2023 | San Francisco, California, United States | ||
Cognito Therapeutics | $73M | 22 Mar 2023 | Cambridge, Massachusetts, United States | ||
Imaginostics | $725K | 06 Sep 2022 | Cambridge, Massachusetts, United States | ||
MindImmune Therapeutics | $12M | 30 Jun 2022 | Rhode Island, United States | ||
Optina Diagnostics | $2M | 24 Jan 2022 | Montreal, Quebec, Canada |